GE Healthcare Technologies Inc
GEHC68.090USD
+0.020+0.03%
Cierre 04/29, 16:00（ET）Cotizaciones retrasadas 15 min
31.11BCap. mercado
15.61P/E TTM
Más Datos de GE Healthcare Technologies Inc Compañía
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Información de la empresa
Código de la empresaGEHC
Nombre de la empresaGE Healthcare Technologies Inc
Fecha de salida a bolsaDec 15, 2022
Fundada en2022
Director ejecutivoMr. Kevin Michael O'Neill
Número de empleados53000
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 15
Dirección500 West Monroe Street
CiudadCHICAGO
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal60661
Teléfono18337351139
Sitio Webhttps://www.gehealthcare.com
Código de la empresaGEHC
Fecha de salida a bolsaDec 15, 2022
Fundada en2022
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.15K
+160.52%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
66.05K
+1.93K%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
31.67K
+19.01%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
9.20K
--
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
8.76K
--
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
8.76K
--
Dr. Risa J. Lavizzo-Mourey, M.D.
Dr. Risa J. Lavizzo-Mourey, M.D.
Lead Independent Director
Lead Independent Director
7.07K
--
Dr. Tomislav Mihaljevic, M.D.
Dr. Tomislav Mihaljevic, M.D.
Independent Director
Independent Director
6.02K
--
Mr. Kevin Michael O'Neill
Mr. Kevin Michael O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics
Chief Executive Officer - Pharmaceutical Diagnostics
165.00
-86.19%
Mr. Lloyd W. Howell, Jr.
Mr. Lloyd W. Howell, Jr.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.15K
+160.52%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
66.05K
+1.93K%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
31.67K
+19.01%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
9.20K
--
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
8.76K
--
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
8.76K
--
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Total Imaging
8.86B
45.01%
Total Ultrasound
5.13B
26.08%
Total PCS
3.13B
15.89%
Total PDx
2.51B
12.75%
Other
52.00M
0.26%
Por regiónUSD
Nombre
Ganancia
Proporción
Other
8.92B
45.34%
United States
8.62B
43.80%
China
2.13B
10.85%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Total Imaging
8.86B
45.01%
Total Ultrasound
5.13B
26.08%
Total PCS
3.13B
15.89%
Total PDx
2.51B
12.75%
Other
52.00M
0.26%
Accionista
Hora de actualización: vie., 21 de feb
Hora de actualización: vie., 21 de feb
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
Capital Research Global Investors
13.29%
The Vanguard Group, Inc.
11.43%
BlackRock Institutional Trust Company, N.A.
5.43%
State Street Global Advisors (US)
4.13%
Dodge & Cox
3.64%
Other
62.08%
Estadísticas de accionistas
Accionista
Proporción
Capital Research Global Investors
13.29%
The Vanguard Group, Inc.
11.43%
BlackRock Institutional Trust Company, N.A.
5.43%
State Street Global Advisors (US)
4.13%
Dodge & Cox
3.64%
Other
62.08%
Tipo
Accionista
Proporción
Investment Advisor
40.35%
Investment Advisor/Hedge Fund
36.91%
Hedge Fund
3.13%
Research Firm
2.52%
Pension Fund
2.22%
Sovereign Wealth Fund
1.44%
Bank and Trust
1.32%
Insurance Company
0.36%
Individual Investor
0.27%
Other
11.47%
Participación institucional
Hora de actualización: dom., 19 de ene
Hora de actualización: dom., 19 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
2333
405.87M
88.75%
-9.18M
2024Q4
2344
405.16M
88.60%
-9.34M
2024Q3
2188
396.50M
86.79%
-11.03M
2024Q2
2081
391.61M
85.76%
-10.20M
2024Q1
2000
385.11M
84.39%
-2.29M
2023Q4
1855
385.99M
84.77%
-4.81M
2023Q3
1708
381.18M
83.73%
+1.51M
2023Q2
1574
374.50M
82.34%
-3.85M
2023Q1
1358
378.91M
83.35%
+182.70M
2022Q4
41
468.43M
103.20%
+468.43M
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Capital Research Global Investors
60.83M
13.3%
+2.61M
+4.48%
Dec 31, 2024
The Vanguard Group, Inc.
52.34M
11.45%
+2.16M
+4.30%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
24.86M
5.44%
+239.16K
+0.97%
Dec 31, 2024
State Street Global Advisors (US)
18.90M
4.13%
+281.45K
+1.51%
Dec 31, 2024
Dodge & Cox
16.68M
3.65%
+11.87K
+0.07%
Dec 31, 2024
Geode Capital Management, L.L.C.
11.32M
2.48%
+342.82K
+3.12%
Dec 31, 2024
Invesco Capital Management (QQQ Trust)
9.45M
2.07%
+126.88K
+1.36%
Feb 28, 2025
Norges Bank Investment Management (NBIM)
6.25M
1.37%
+1.84M
+41.76%
Dec 31, 2024
AllianceBernstein L.P.
6.13M
1.34%
-220.13K
-3.47%
Dec 31, 2024
Hotchkis and Wiley Capital Management, LLC
5.58M
1.22%
-18.35K
-0.33%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: dom., 6 de abr
Hora de actualización: dom., 6 de abr
Nombre
Proporción
Langar Global HealthTech ETF
10.47%
Invesco S&P Spin-Off ETF
7.54%
Otter Creek Focus Strategy ETF
4.86%
Absolute Select Value ETF
4.37%
iShares U.S. Medical Devices ETF
3.93%
Capital Group Dividend Value ETF
2.81%
VanEck Morningstar Wide Moat Value ETF
2.69%
VanEck Morningstar Wide Moat ETF
2.38%
VanEck Morningstar Wide Moat Growth ETF
1.99%
Themes US R&D Champions ETF
1.97%
Ver más
Langar Global HealthTech ETF
Proporción10.47%
Invesco S&P Spin-Off ETF
Proporción7.54%
Otter Creek Focus Strategy ETF
Proporción4.86%
Absolute Select Value ETF
Proporción4.37%
iShares U.S. Medical Devices ETF
Proporción3.93%
Capital Group Dividend Value ETF
Proporción2.81%
VanEck Morningstar Wide Moat Value ETF
Proporción2.69%
VanEck Morningstar Wide Moat ETF
Proporción2.38%
VanEck Morningstar Wide Moat Growth ETF
Proporción1.99%
Themes US R&D Champions ETF
Proporción1.97%
Dividendos
Un total de
96.00M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Nov 21, 2024
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 14, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Feb 14, 2025
Jan 14, 2025
Sep 18, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 15, 2024
Oct 18, 2024
Jun 26, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 15, 2024
Jul 19, 2024
Mar 22, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on May 15, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 15, 2024
Apr 18, 2024
Dec 08, 2023
GEHC.NB Final Cash Dividend of gross USD 0.03 paid on Feb 15, 2024 going ex on Jan 12, 2024
Jan 16, 2024
Feb 15, 2024
Jan 12, 2024
Sep 22, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 15, 2023
Oct 19, 2023
Jun 23, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 15, 2023
Jul 20, 2023
Apr 25, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Jun 15, 2023 going ex on May 22, 2023
May 23, 2023
Jun 15, 2023
May 22, 2023
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos